World Health Investigation Podcast podcast

“Fat people can’t do pilates”: Ozempic and Fatphobia

0:00
26:49
Rewind 15 seconds
Fast Forward 15 seconds

Send us Fan Mail

Weight loss drugs are changing what’s medically possible, but are they changing what we expect from bodies too? In this episode, we unpack obesity, GLP-1 drugs like Ozempic and Wegovy, and the tension between public health and fatphobia. We discuss whether these medications address a global health crisis, or if they are just reshaping weight stigma with better branding. 

Enjoyed the episode? Please leave a like, comment or subscribe :) 

Key sources:

  1. World Health Organization (2024). Obesity and Overweight.
    https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  2. Ryan et al. (2023). Weight stigma experienced by patients with obesity in healthcare settings: A qualitative evidence synthesis.
    https://onlinelibrary.wiley.com/doi/10.1111/obr.13606
  3. Heitmann (2025). The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review. 
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11799028/

McWhorter, K. L. (2020). Obesity Acceptance: Body Positivity and Clinical Risk Factors. https://www.intechopen.com/chapters/73236 

Support the show

Follow us on our socials so you don’t miss anything!

More episodes from "World Health Investigation Podcast"